SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 229.88 |
| Enterprise Value ($M) | 223.26 |
| Book Value ($M) | 146.32 |
| Book Value / Share | 0.87 |
| Price / Book | 1.57 |
| NCAV ($M) | 62.87 |
| NCAV / Share | 0.37 |
| Price / NCAV | 3.66 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.76 |
| Return on Assets (ROA) | -0.42 |
| Return on Equity (ROE) | -0.48 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 5.81 |
| Current Ratio | 5.81 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 114.07 |
| Assets | 197.52 |
| Liabilities | 51.20 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Apeiron Investment Group Ltd. | 20.10 | 3.72 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q/A | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 2,024,929 | 5,816,899 | 34.81 | |
| 523,510 | 1,675,143 | 31.25 | |
| 580,403 | 2,398,918 | 24.19 | |
| 1,003,178 | 2,886,020 | 34.76 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| AQST – Aquestive Therapeutics, Inc. | ARCT – Arcturus Therapeutics Holdings Inc. |
| ARDX – Ardelyx, Inc. | ATXS – Astria Therapeutics, Inc. |
| AUPH – Aurinia Pharmaceuticals Inc. |
Financial data and stock pages provided by
Fintel.io